Simplex Trading
NBSE icon

Simplex Trading’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Simplex Trading’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-86
Closed – – 10235
2023
Q1 		$0 Buy
+86
New +$397 ﹤0.01% 10445
2022
Q4 		– Sell
-9
Closed -$46 – 10775
2022
Q3 		$0 Buy
+9
New +$149 ﹤0.01% 11150
2022
Q2 		– Sell
-266
Closed -$6.24K – 11413
2022
Q1 		$9K Sell
266
-150
-36% -$5.19K ﹤0.01% 9005
2021
Q4 		$23K Buy
416
+171
+70% +$11.5K ﹤0.01% 8227
2021
Q3 		$23K Hold
245
– – ﹤0.01% 8333
2021
Q2 		$23K Sell
245
-573
-70% -$63.3K ﹤0.01% 8480
2021
Q1 		$120K Buy
818
+707
+637% +$128K ﹤0.01% 5485
2020
Q4 		$15K Buy
+111
New +$18K ﹤0.01% 7175
2018
Q2 		– Sell
-12
Closed -$1.05K – 8015
2018
Q1 		$1K Buy
12
+6
+100% +$892 ﹤0.01% 5854
2017
Q4 		$4K Buy
6
+3
+100% +$1.16K ﹤0.01% 4773
2017
Q3 		$0 Buy
+3
New +$819 ﹤0.01% 6823
2017
Q2 		– Sell
-6
Closed -$1.61K – 6955
2017
Q1 		$2K Buy
6
+1
+20% +$463 ﹤0.01% 5393
2016
Q4 		$2K Hold
5
– – ﹤0.01% 5162
2016
Q3 		$5K Sell
5
-11
-69% -$11.9K ﹤0.01% 4346
2016
Q2 		$17K Buy
+16
New +$20.1K ﹤0.01% 3063
2016
Q1 		– Sell
-14
Closed -$19.9K – 6409
2015
Q4 		$34K Sell
14
-27
-66% -$41.4K ﹤0.01% 2253
2015
Q3 		$45K Buy
+41
New +$47.5K ﹤0.01% 2080
2015
Q2 		– Sell
-1
Closed -$1.08K – 6004
2015
Q1 		$0 Buy
+1
New +$3.3K ﹤0.01% 5753

Other funds holding NBSE

Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Greenlight Capital
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Decheng Capital Management III (Cayman)
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
Carnegie Mellon University
Carnegie Mellon University Pittsburgh, Pennsylvania $78.9M AUM 38.67% 1-Year Est. Return
Kestra Advisory Services
Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Prelude Capital Management
Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return
Jacob Asset Management of New York
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Simplex Trading's NBSE Position: Q2 2023 in Review

Simplex Trading sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q2 2023, closing a stake of 86 shares.

Simplex Trading first reported a position in NBSE in Q1 2015 and held it in 18 quarters. The position peaked at $120K in Q1 2021. 27 funds tracked by Wall St. Rank hold NBSE as of Q2 2023.

  • Simplex Trading reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 86 NeuBase Therapeutics, Inc. Common Stock shares in Q2 2023.
  • Simplex Trading first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2015 and held it in 18 quarters.
  • Simplex Trading's NeuBase Therapeutics, Inc. Common Stock position peaked at $120K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.